<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.3390/molecules27041293</dc:identifier><dc:language>eng</dc:language><dc:creator>Xu, Catherine K.</dc:creator><dc:creator>Castellana-Cruz, Marta</dc:creator><dc:creator>Chen, Serene W.</dc:creator><dc:creator>Du, Zhen</dc:creator><dc:creator>Meisl, Georg</dc:creator><dc:creator>Levin, Aviad</dc:creator><dc:creator>Mannini, Benedetta</dc:creator><dc:creator>Itzhaki, Laura</dc:creator><dc:creator>Knowles, Tuomas P. J.</dc:creator><dc:creator>Dobson, Christopher</dc:creator><dc:creator>Cremades, Nunilo</dc:creator><dc:creator>Kumita, Janet R.</dc:creator><dc:title>The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity</dc:title><dc:identifier>ART-2022-131233</dc:identifier><dc:description>A wide variety of oligomeric structures are formed during the aggregation of proteins associated with neurodegenerative diseases. Such soluble oligomers are believed to be key toxic species in the related disorders; therefore, identification of the structural determinants of toxicity is of upmost importance. Here, we analysed toxic oligomers of α-synuclein and its pathological variants in order to identify structural features that could be related to toxicity and found a novel structural polymorphism within G51D oligomers. These G51D oligomers can adopt a variety of β-sheet-rich structures with differing degrees of α-helical content, and the helical structural content of these oligomers correlates with the level of induced cellular dysfunction in SH-SY5Y cells. This structure–function relationship observed in α-synuclein oligomers thus presents the α-helical structure as another potential structural determinant that may be linked with cellular toxicity in amyloid-related proteins.</dc:description><dc:date>2022</dc:date><dc:source>http://zaguan.unizar.es/record/120203</dc:source><dc:doi>10.3390/molecules27041293</dc:doi><dc:identifier>http://zaguan.unizar.es/record/120203</dc:identifier><dc:identifier>oai:zaguan.unizar.es:120203</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/MCIU-FEDER/PGC2018-096335-B-100</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO/RYC-2012-12068</dc:relation><dc:identifier.citation>Molecules 27, 4 (2022), 1293 [14 pp.]</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>http://creativecommons.org/licenses/by/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>